|
PPARA expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62458935193399E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62447832963153E-12 |
| Normal-vs-Stage2 |
1.2011000000145E-06 |
| Normal-vs-Stage3 |
9.05449999977215E-07 |
| Normal-vs-Stage4 |
7.93780041696834E-10 |
| Stage1-vs-Stage2 |
6.327000E-01 |
| Stage1-vs-Stage3 |
4.246000E-01 |
| Stage1-vs-Stage4 |
9.089900E-02 |
| Stage2-vs-Stage3 |
8.663400E-01 |
| Stage2-vs-Stage4 |
8.711500E-02 |
| Stage3-vs-Stage4 |
3.027600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62470037423645E-12 |
| Normal-vs-AfricanAmerican |
1.52050039226026E-10 |
| Normal-vs-Asian |
2.21039999999117E-05 |
| Caucasian-vs-AfricanAmerican |
1.781030E-01 |
| Caucasian-vs-Asian |
7.754400E-02 |
| AfricanAmerican-vs-Asian |
1.248640E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62436730732907E-12 |
| Normal-vs-Female |
6.75759448398594E-12 |
| Male-vs-Female |
6.826200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.08553224374009E-12 |
| Normal-vs-Extreme_Weight |
6.37140340487008E-11 |
| Normal-vs-Obese |
4.90110174666825E-11 |
| Normal-vs-Extreme_Obese |
6.201600E-04 |
| Normal_Weight-vs-Extreme_Weight |
7.368600E-01 |
| Normal_Weight-vs-Obese |
1.460240E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.279380E-01 |
| Extreme_Weight-vs-Obese |
2.904000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.168200E-02 |
| Obese-vs-Extreme_Obese |
5.052600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.51909629109559E-11 |
| Normal-vs-Age(41-60Yrs) |
1.22440002581214E-09 |
| Normal-vs-Age(61-80Yrs) |
4.2854608750531E-14 |
| Normal-vs-Age(81-100Yrs) |
2.47299999999173E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.122200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.057600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.029800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.551200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.792600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.678200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.03040054056214E-10 |
| Normal-VS-Type2 PRCC |
1.84809999526081E-08 |
| Normal-VS-KIRP CIMP |
2.52600051986462E-10 |
| Normal-VS-Unclassified PRCC |
1.13050000472015E-08 |
| Type1 PRCC-VS-Type2 PRCC |
3.197600E-02 |
| Type1 PRCC-VS-KIRP CIMP |
6.769900E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
6.087800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.355300E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
2.860400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.571600E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.6352004153033E-10 |
| Normal-vs-N1 |
8.95639999942688E-08 |
| Normal-vs-N2 |
4.558100E-04 |
| N0-vs-N1 |
5.589800E-01 |
| N0-vs-N2 |
2.761000E-01 |
| N1-vs-N2 |
4.622800E-01 |
|
|
